Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Sex Transm Dis. 2016 Feb;43(2):105–109. doi: 10.1097/OLQ.0000000000000384

Table 2.

Symptoms experienced by site of infection

Men No infection
number (%)
n=144		 Positive GC
number (%)
n = 51, (%)		 p-value GC Positive CT
number (%)
n = 49		 p-value CT
 Any Site 41 (28.5) 24 (47.1) 0.02 21 (42.9) 0.08
 Rectal 17 (11.8) 10 (19.6) 0.17 10 (20.4) 0.15
 Pharynx 21 (14.6) 8 (15.7) 0.82 7 (14.3) >0.99
 Urinary 10 (6.9) 12 (23.5) 0.001 9 (18.4) 0.08
Women No infection
n=149, (%)		 Positive
n = 6, (%)		 Positive
n = 22, (%)
 Any Site 66 (44.3) 5 (83.3) 0.09 12 (54.5) 0.49
 Rectal 10 (6.7) 0 >0.99 0 0.36
 Pharynx 17 (11.4) 4 (66.7) 0.003 7 (31.8) 0.02
 Vaginal 58 (38.9) 4 (66.7) 0.22 8 (36.4) >0.99

CT: Chlamydia trachomatis, GC: Neisseria gonorrhoeae